AGG Talks: Cross-Border Business Podcast - Episode 27: U.S. Healthcare Reimbursement Guidance for Foreign Life Sciences Companies
AGG Talks: Cross-Border Business Podcast - Episode 26: U.S. Enforcement Trends Targeting Foreign Pharmaceutical and Medical Device Manufacturers
AGG Talks: Cross-Border Business Podcast - Episode 25: Venture Capital Trends and Fundraising Strategies for Foreign Startups Expanding to the U.S.
Everyone Come to Play: Exploring FOCI Mitigation Instruments
AGG Talks: Cross-Border Business Podcast - Episode 20: Mastering ITC Section 337 Investigations
AGG Talks: Cross-Border Business Podcast - Episode 19: The Rise of Korean Investment in the Southeast U.S.
Scaling Success: Hanley Energy’s Journey From Ireland to the U.S.
Forming friendships, cross border referrals and mentoring with Paul Beare
Compliance Tip of the Day: Cross Border Investigations, Part 1
JONES DAY PRESENTS®: Cross-Border Trade Secret Litigation in the United States
AGG Talks: Cross-Border Business - Navigating Business Etiquette and Intercultural Communications Around the Globe
Garnishment Practices: Has the Dust Settled or Is It Still Flying? — The Consumer Finance Podcast
The Standard Formula Podcast | Solvency II Back to Basics: Third Country Branches and Cross-Border Provision of Services
La caída de las normas especiales de insolvencia
Strategy Considerations for Global Litigation
Chapter 15 Bankruptcy Issues, Venue, and Jurisdiction by Kristhy Peguero and Jennifer Wertz
Viewpoints: President José María Aznar Examines Economic Landscape in Latin America
Podcast: International Risks Facing Latin America Companies
One Month to Better Investigations and Reporting-Day 10-Best Practices in a Cross-Border Investigation
FCPA Compliance and Ethics Report-Episode 167-Mara Senn on the Top 10 Practices in a Cross-Border Investigation
In this episode, Mike Burke, AGG Corporate partner and co-chair of the firm’s International practice, is joined by Andrew Tsui, AGG Healthcare Litigation partner, to explore the intricacies of reimbursement in the U.S....more
Report on Research Compliance 17, no. 2 (January 23, 2020) - - More than two years after Ozgur Tataroglu’s paper was retracted, the HHS Office of Research Integrity found that it and two grant applications contained...more